Litha Pharma



 This market has been a key strategic growth area for the Litha Group and 2012 it acquired the Pharmaplan business and aligned itself with Paladin Labs Inc of Canada to ensure product continuity and long-term sustainable growth. With the recent acquisition of Litha by Endo International plc, this business will have access to new product pipelines and will benefit from international expertise which comes from being part of a global, multinational business. 

Litha Pharma already has numerous licence agreements, co-marketing and joint ventures with international healthcare companies and will continue to do so. Access and ownership to product pipelines is an intrinsic part of its long-term strategy and Litha Pharma has many exciting new products in various stages of registration at the Medicines Control Council.

Litha Pharma’s current business focus is to develop greater market presence in all its distribution channels as well as to expand access to prescribing healthcare professionals in both the public and private sector. This includes specialists and GP’s, commercial areas (pharmacies and fast moving consumer goods), dispensing doctors, mines and the public tender sector.

Key therapeutic areas of focus include:

Gastroenterology                       Anaesthesiology
Neurology                                 Urology
Dermatology                             Psychiatry
Nephrology                               Cardiology                              
Gynaecology                            Ophthalmology
Allergology                               ENT                                        
Pain Management                                           

Litha Pharma has a growing range of complementary medicines which includes brands like Formule Naturelle, Smecta and various skin care ranges.

For more information contact:
Helen Pemberton
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Litha Pharma is a member of the Health Products Association of Southern Africa (HPASA) and National Association of Pharmaceutical Manufacturers (NAPM).